Succinic acid 1 g, nicotinamide 0.1 g, inosine 0.2 g, riboflavin Na phosphate 0.02 g
Indications/Uses
Addition to standard therapy for moderate stage of acute ischaemic stroke, to be administered w/in 1st 6-24 hr after the onset of stroke symptoms & residual symptoms (sequelae) of ischemic stroke which occurred w/in previous 25-30 days.
Moderate acute ischemic stroke 10 mL single dose w/ 8-12 hrly interval for 10 consecutive days. Sequelae of ischemic stroke 10 mL single dose once daily for 10 consecutive days.
Hypersensitivity. Critically ill patients until central haemodynamic parameters become normal &/or partial pressure of arterial O2 is <60 mmHg. Pregnancy & lactation. Childn 0-18 yr.